Scarica l'app Stockscreener
24.31
1.90%
0.4126
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$23.90
Aprire:
$24.24
Volume 24 ore:
1.67M
Relative Volume:
0.49
Capitalizzazione di mercato:
$4.49B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
20.42
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
+15.10%
1M Prestazione:
-0.96%
6M Prestazione:
-63.83%
1 anno Prestazione:
-53.86%
Intervallo 1D:
$24.10
$25.00
Intervallo di 1 settimana:
$20.87
$25.00
Portata 52W:
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.32 | 4.41B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
168.52 | 27.33B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
54.80 | 10.12B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
45.81 | 8.89B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
84.50 | 7.07B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.57 | 4.73B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $47 - Moomoo
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Call Transcript - MSN
GitLab, Twilio, and Doximity Shares Skyrocket, What You Need To Know - Yahoo Finance
BofA cuts Doximity stock price target on transition year outlook By Investing.com - Investing.com South Africa
BofA cuts Doximity stock price target on transition year outlook - Investing.com
Why Doximity Activity Is Turning Heads in Healthcare Tech? - Kalkine Media
Doximity Insider Sells $51,000 in Shares - National Today
Insider Selling: Doximity (NYSE:DOCS) Insider Sells 2,427 Shares of Stock - MarketBeat
AI Disruption Jitters and Insider Sales Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity interim PFO Sitaram sold $51k in DOCS stock By Investing.com - Investing.com Australia
Doximity interim PFO Sitaram sold $51k in DOCS stock - Investing.com
Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Doximity (NYSE: DOCS) interim PFO sells shares to cover option taxes - Stock Titan
Doximity, Inc. Stock Plummets to New 52-Week Low of $20.55 - Markets Mojo
Here is Why Doximity (DOCS) Still Appears Attractive - Insider Monkey
Can Doximity (DOCS) Turn Its Physician-Focused AI Ecosystem Into Durable Financial Strength? - Yahoo Finance
Is Doximity (NYSE:DOCS) Gaining Traction on The Russell 1000 Index? - Kalkine Media
DOCS Maintained by Keybanc -- Price Target Lowered to $30 - GuruFocus
Assessing Doximity (DOCS) Valuation After Soft Guidance And Rising AI Competition Concerns - Yahoo Finance
KeyCorp Issues Pessimistic Forecast for Doximity (NYSE:DOCS) Stock Price - MarketBeat
Doximity (DOCS) Slid on Concerns Over AI Disruption - Insider Monkey
KeyBanc Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $30 - Moomoo
Sentiment Review: Is Doximity Inc stock a hidden gemWeekly Market Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Doximity, Inc. $DOCS Shares Sold by Baillie Gifford & Co. - MarketBeat
Anthropic Managed Agents Test Doximity’s Workflow Moat And Pricing Power - Sahm
Could Anthropic Managed Agents Pressure The Doximity SaaS Business Model - Yahoo Finance
Is Doximity (DOCS) one of the stocks set to explode in the next 3 years? - MSN
VIP Mid Cap Portfolio's Doximity Inc(DOCS) Holding History - GuruFocus
Affiliate (DOCS) Form 144: Option-exercise sale handled by Morgan Stanley (DOCS) - Stock Titan
Doximity, Inc. Hits New 52-Week Low at $21.66 Amid Declining Stock Performance - Markets Mojo
Doximity, Inc. (DOCS) Stock forecasts - Yahoo Finance UK
Is Doximity Inc (DOCS) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Lowers Price Target for Doximity (DOCS) to $28 | D - GuruFocus
Is Doximity (DOCS) One of the Stocks Set to Explode in the Next 3 Years? - Insider Monkey
Doximity (NYSE:DOCS) Given New $28.00 Price Target at The Goldman Sachs Group - MarketBeat
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $28 - Moomoo
Evercore ISI Group downgrades Doximity (DOCS) - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $28 - Moomoo
15 Stocks Set to Explode in the Next 3 Years - Insider Monkey
A Look Back at Vertical Software Stocks’ Q4 Earnings: Doximity (NYSE:DOCS) Vs The Rest Of The Pack - Yahoo Finance
Doximity (NYSE:DOCS) Sets New 52-Week Low Following Analyst Downgrade - MarketBeat
Doximity stock hits 52-week low at 21.81 USD By Investing.com - za.investing.com
Doximity stock hits 52-week low at 21.81 USD - Investing.com
Doximity (NYSE:DOCS) Downgraded to "In-Line" Rating by Evercore - MarketBeat
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Coinbase Global, Diamondback Energy, Deere, Doximity, Dutch Bros., Johnson & Johnson, Robinhood Markets, Verizon and More - AOL.com
Doximity (NYSE:DOCS) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Evercore Downgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $25 - Moomoo
Evercore ISI cuts Doximity stock rating on slower market growth By Investing.com - Investing.com India
Evercore ISI cuts Doximity stock rating on slower market growth - Investing.com
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year? - MSN
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.23%
5.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):